[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)]. 2023

Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
Avomed - Arbeitskreis für Vorsorgemedizin zbd Gesundheitsförderung in Tirol, Innsbruck, Österreich.

This guideline summarizes diagnosis of type 1 diabetes, including accompanying autoimmune disorders, insulin therapy regimens and glycemic target values.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
January 2023, Wiener klinische Wochenschrift,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
May 2015, Der Internist,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
March 2024, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
December 1999, Primary care,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
April 2012, The New England journal of medicine,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
July 2012, The New England journal of medicine,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
January 2006, Jornal de pediatria,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
April 2015, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
January 2023, Wiener klinische Wochenschrift,
Monika Lechleitner, and Susanne Kaser, and Friedrich Hoppichler, and Michael Roden, and Raimund Weitgasser, and Bernhard Ludvik, and Peter Fasching, and Yvonne Winhofer, and Alexandra Kautzky-Willer, and Guntram Schernthaner, and Rudolf Prager, and Thomas C Wascher, and Martin Clodi
January 2023, Wiener klinische Wochenschrift,
Copied contents to your clipboard!